# A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients

> **NCT00239174** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 394 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** SR147778

## Key facts

- **NCT ID:** NCT00239174
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 394 (ACTUAL)
- **Last updated:** 2008-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239174, "A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00239174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*